ATE214921T1 - Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird - Google Patents

Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird

Info

Publication number
ATE214921T1
ATE214921T1 AT95905401T AT95905401T ATE214921T1 AT E214921 T1 ATE214921 T1 AT E214921T1 AT 95905401 T AT95905401 T AT 95905401T AT 95905401 T AT95905401 T AT 95905401T AT E214921 T1 ATE214921 T1 AT E214921T1
Authority
AT
Austria
Prior art keywords
potassium channel
channel agonist
trichoderma virens
new potassium
agonist derived
Prior art date
Application number
AT95905401T
Other languages
English (en)
Inventor
Maria L Garcia
Robert A Giacobbe
Otto D Hensens
Gregory J Kaczorowski
Seok H Lee
Owen B Mcmanus
Deborah L Zink
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE214921T1 publication Critical patent/ATE214921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95905401T 1993-12-13 1994-12-09 Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird ATE214921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/166,499 US5399587A (en) 1993-12-13 1993-12-13 Biologically active compounds
PCT/US1994/014491 WO1995016442A1 (en) 1993-12-13 1994-12-09 Novel potassium channel agonist produced from trichoderma virens

Publications (1)

Publication Number Publication Date
ATE214921T1 true ATE214921T1 (de) 2002-04-15

Family

ID=22603577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95905401T ATE214921T1 (de) 1993-12-13 1994-12-09 Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird

Country Status (8)

Country Link
US (1) US5399587A (de)
EP (1) EP0734255B1 (de)
JP (1) JPH09506627A (de)
AT (1) ATE214921T1 (de)
AU (1) AU689193B2 (de)
CA (1) CA2179068A1 (de)
DE (1) DE69430259D1 (de)
WO (1) WO1995016442A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050153940A1 (en) * 2000-01-26 2005-07-14 Cedars-Sinai Medical Center Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
US7018979B1 (en) 2000-01-26 2006-03-28 Cedars-Sinai Medical Center Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
US7211561B2 (en) * 2001-10-12 2007-05-01 Cedars-Sinai Medical Center Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa)
EP1850852A4 (de) * 2005-02-22 2009-11-18 Cedars Sinai Medical Center Verwendung von sildenafil, vardenafil und anderen 5-phosphodiesterase-hemmern zur erhöhung der durchlässigkeit der abnormalen blut-hirn-schranke
CN108640832B (zh) * 2018-04-23 2020-10-09 中国科学院烟台海岸带研究所 一种杜松烷倍半萜类化合物及其制备和应用
CN108373457B (zh) * 2018-04-23 2021-04-06 中国科学院烟台海岸带研究所 一种环氧倍半萜类化合物及其制备和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130250A (ja) * 1984-11-30 1986-06-18 Taisho Pharmaceut Co Ltd 抗生物質ｃａｆ−０６０３
US4831033A (en) * 1987-04-16 1989-05-16 City Of Hope Use of amodiaquin in treatment of nervous system degeneration
EP0310410A3 (de) * 1987-10-02 1990-01-17 Kawate, Tsuneyoshi Kalziumbeschleunigte Kalium-Flut-Kontrolle von geschädigten Körperzellen
US5006512A (en) * 1987-10-02 1991-04-09 Tsuyoshi Ohnishi Therapeutic usages of inhibitors for a potassium efflux channel
US4929718A (en) * 1987-12-14 1990-05-29 Universidad Nacional Autonoma De Mexico Synthetic noxiustoxin related peptides
EP0408650A1 (de) * 1988-04-08 1991-01-23 Massachusetts Institute Of Technology Verfahren und zusammensetzung für die behandlung neurologischer störungen
DE3825561A1 (de) * 1988-07-28 1990-02-01 Basf Ag P-hydroxiphenon-derivate und diese enthaltende arzneimittel
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5112824A (en) * 1989-12-08 1992-05-12 Merck & Co., Inc. Benzofuran compounds as class III antiarrhythmic agents
GB9005318D0 (en) * 1990-03-09 1990-05-02 Isis Innovation Antiarrhythmic agents
CA2044853C (en) * 1990-07-19 2004-11-09 Susan A. Greenfield Method for treating parkinson's disease employing an atp-sensitive potassium channel blocker
CA2044855A1 (en) * 1990-07-20 1992-01-21 Kerry P. S. J. Murphy Method for treating insult to neurons prone to parkinson's degeneration employing an atp-sensitive potassium channel blocker
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers

Also Published As

Publication number Publication date
CA2179068A1 (en) 1995-06-22
US5399587A (en) 1995-03-21
EP0734255A1 (de) 1996-10-02
AU689193B2 (en) 1998-03-26
DE69430259D1 (de) 2002-05-02
JPH09506627A (ja) 1997-06-30
WO1995016442A1 (en) 1995-06-22
EP0734255B1 (de) 2002-03-27
AU1402695A (en) 1995-07-03
EP0734255A4 (de) 1997-04-02

Similar Documents

Publication Publication Date Title
ES2163638T3 (es) Nuevas n-(1-alquil-5-fenil-2,3,4,5-tetrahidro-1h-benzo(b)(1,5)diacepin-3-il)acetamidas.
EG19647A (en) Neuroprotective indolone and related derivatives
GR3032161T3 (en) Amido siladiyl bridged catalyst components, methods of making and using
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
PA8464901A1 (es) Procesos para la sintesis de 1,3-dioles
EP0863755A4 (de) Antithrombotische diamine
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
ES477832A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano.
ES2176456T3 (es) Procedimiento de preparacion de un compuesto inhibidor del vih proteasa.
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
RU94022277A (ru) Новые 19-норстероиды, имеющие в положении 11 - бета феноксиалкилсульфонамидную или феноксиалкилсульфонилкарбамидную цепь, метод и промежуточные продукты их получения, и содержащая их фармацевтическая композиция
ATE214921T1 (de) Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
RU94026252A (ru) Модифицированные эластомерные полипропилены, способ модификации эластомерных полипропиленов, композиция на основе полиолефинов и неолефиновых термопластов
DE69705721D1 (de) Verfahren zur Herstellung von 3-Isochromanon
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
DK0804186T3 (da) Indolditerpenalkaloidforbindelser
DE59811798D1 (de) Verfahren zur herstellung von 5-aminomethyl-2-chlorpyridinen
ES2175842T3 (es) Antagonistas de kv2.1.
ES8400401A1 (es) "un procedimiento para preparar un 1,4-dialcohilo inferior-3-alcoxicarbonilo inferior-pirrol-2-acetato de alcohilo inferior".
ES2157232T3 (es) Procedimiento para la preparacion de 2,4,5-tribromo-pirrol-3-carbonitrilo.
ATE179167T1 (de) Antivirale analoge von difluorostaton
ES2152982T3 (es) Analogos de la difluoroestatona.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties